Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial

Authors

Luigi Dogliotti

Published

January 2, 2007

Abstract

Supporters

Support the authors with ResearchCoin

Journal

European Urology

Topics

DOI

10.1016/j.eururo.2006.12.029

Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial

Authors

Luigi Dogliotti

Published

January 2, 2007

Abstract

Supporters

Support the authors with ResearchCoin

Journal

European Urology

Topics

DOI

10.1016/j.eururo.2006.12.029

Paper

Paper

Paper

Paper

Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial

Abstract

Supporters

Journal

Topics

DOI

Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial

Abstract

Supporters

Journal

Topics

DOI